Epigenetic polypharmacology: from combination therapy to multitargeted drugs.
Ontology highlight
ABSTRACT: The modern drug discovery process has largely focused its attention in the so-called magic bullets, single chemical entities that exhibit high selectivity and potency for a particular target. This approach was based on the assumption that the deregulation of a protein was causally linked to a disease state, and the pharmacological intervention through inhibition of the deregulated target was able to restore normal cell function. However, the use of cocktails or multicomponent drugs to address several targets simultaneously is also popular to treat multifactorial diseases such as cancer and neurological disorders. We review the state of the art with such combinations that have an epigenetic target as one of their mechanisms of action. Epigenetic drug discovery is a rapidly advancing field,
SUBMITTER: de Lera AR
PROVIDER: S-EPMC5062873 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
ACCESS DATA